GlobalData’s analysis of the cell and gene therapy (CGT) investment landscape highlights key trends and opportunities shaping this rapidly evolving…
Browsing: Strategic
Novartis plans to pursue more bolt-on acquisitions to enhance its portfolio, with a continued focus on strategic therapeutic areas including…
Health data governance is evolving from a compliance function to a strategic asset, playing a crucial role in areas such…
Merck CEO Rob Davis announced that the company is transforming its portfolio beyond its reliance on the cancer drug Keytruda.…
Maia Fertility has secured a joint investment from Mercantile Life Science Ventures IV and Big Idea Ventures’ Generation Food Rural…
Jasper Therapeutics has secured a financial lifeline by merging with Kira Pharmaceuticals, a private immune drug developer, in an all-stock…
Adaptive Biotechnologies (ADPT) shares are experiencing a decline, currently down 1.60% at $16.94. A recent investor note from William Blair…
Eli Lilly (LLY) has announced its plan to acquire three biotech companies—Curevo, LimmaTech Biologics, and Vaccine Company—for a total of…
The Ministry of Higher Education, Science, and Technology of Indonesia is enhancing collaboration with Turkiye in various areas, including higher…
Summary of Key Developments at Vir Biotechnology Vir Biotechnology remains a significant player in the biotech sector, particularly for U.S.…